You are viewing: Australia Pharmaceutical Packaging Market analysis

The Australia Pharmaceutical Packaging Market was valued at $4116.1 Million in 2025 and projected to reach to $9231.4 Million by 2030, representing a compound annual growth rate of 17.5%. Australia's pharmaceutical packaging market is poised for sustained growth through 2030, driven by escalating demand for sophisticated packaging technologies that meet stringent regulatory standards and protect sensitive pharmaceutical products.

Australia Pharmaceutical Packaging Market Trends and Insights

  • This represents a compound annual growth rate of 17.5%, significantly outpacing global trends and reflecting Australia's strengthening position in the Asia Pacific pharmaceutical sector.
  • Australia's market growth is driven by increasing regulatory compliance requirements, rising demand for advanced drug delivery systems, and expansion of biopharmaceutical manufacturing capabilities across the country. The Australian pharmaceutical packaging landscape is characterized by heightened investment in sustainable and innovative packaging solutions.
  • Australia's healthcare infrastructure modernization and growing export-oriented pharmaceutical production are key catalysts propelling market expansion through 2030.
  • Australia's emphasis on quality assurance and stringent therapeutic goods administration standards continues to elevate packaging standards and create opportunities for premium packaging solutions tailored to Australia's regulated environment..

Key Market Statistics

  • CAGR (2025-2030) 17.5% CAGR
  • Market Size, 2025 ~USD 4116.1 Million
  • Forecast, 2030 ~USD 9231.4 Million
  • Country Australia

Australia Pharmaceutical Packaging Market Overview

Exceptional Growth Trajectory :

Australia's pharmaceutical packaging market is expanding at 17.5% CAGR, significantly outpacing the global rate of 15.8%, demonstrating the country's accelerating demand for advanced packaging solutions in the pharmaceutical sector.

Substantial Market Valuation :

The Australian market is valued at $4,116.1 million in 2025 and is projected to more than double to $9,231.4 million by 2030, reflecting strong investment and infrastructure development in the region.

Asia-Pacific Leadership Position :

Australia is strengthening its position as a key player in the Asia Pacific pharmaceutical sector, driven by regulatory compliance requirements, increased domestic manufacturing, and growing export opportunities.

Rising Pharmaceutical Demand :

Increasing healthcare expenditure, aging population demographics, and expansion of biopharmaceutical production in Australia are driving robust demand for innovative and compliant packaging solutions.

Australia Pharmaceutical Packaging Market Dynamics

  • The country's aging population and rising chronic disease prevalence are fueling pharmaceutical consumption, necessitating advanced packaging innovations including child-resistant containers, tamper-evident solutions, and sustainable materials. The market will benefit from increased investment in domestic pharmaceutical manufacturing, growing biopharmaceutical sector expansion, and Australia's strategic position as a regional hub for Asia-Pacific pharmaceutical distribution.
  • Regulatory pressures for compliance with TGA standards and international quality requirements will continue to drive adoption of premium packaging solutions, positioning Australia as a high-value market for packaging manufacturers and suppliers..

Related Ecosystem

Resins And Polymers

Top Technologies
  • Polycarbonate
  • Acrylonitrile Butadiene Styrene (ABS)
  • Epoxy Resin
  • Light Commercial Vehicles (LCVs)
  • Polypropylene (PP)
Top Companies
  • Basf se
  • DOW CHEMICAL COMPANY
  • Solvay sa
  • Saudi arabia basic industries corporation (sabic)
  • DuPont de Nemours, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Packaging

      Top Technologies
      • Ampoules
      • Gravure Process
      • Rigid Packaging
      • Aerosols
      • Aseptic Filling and Sealing Equipment
      Top Companies
      • Amcor plc
      • Essentra plc
      • Berry Global Group, Inc.
      • Mondi plc
      • SEALED AIR CORPORATION

        Key Takeaways

        • Australia's pharmaceutical packaging market will more than double from $4,116.1M (2025) to $9,231.4M (2030), driven by 17.5% CAGR growth.
        • Australia's regulatory environment and TGA compliance requirements are elevating demand for advanced, compliant packaging solutions.
        • Australia's biopharmaceutical sector expansion and export growth are creating sustained demand for innovative packaging technologies.
        • Australia's sustainability focus is reshaping packaging preferences toward eco-friendly and recyclable materials in the pharmaceutical sector.

        Pharmaceutical Packaging Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment PREFILLED SYRINGES (Type)
        Forecast Period 2025–2030
        Growth Rate CAGR of 15.8% from 2025 to 2030
        Largest Segment INJECTABLE (Drug Delivery)
        Market Size Base Year (Billions) ~USD 174.86 (2025)
        Revenue Forecast (Billions) ~USD 364.11 (2030)
        Segments Covered Raw Material, Drug Delivery, Type, Packaging Type, Drug Delivery Mode

        Australia Pharmaceutical Packaging Market Report Segmentation

        5 segment dimensions are covered across the global market.

        By Raw Material

        • Glass
        • Metal
        • Other Raw Materials
        • Paper & Paperboard
        • Plastic
        • Plastics

        By Drug Delivery

        • Injectable
        • Injectables
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Oral Drugs
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        By Type

        • Ampoules
        • Blister Packs
        • Caps & Closures
        • Cartridges
        • Jars & Canisters
        • Labels & Accessories
        • Medical Specialty Bags
        • Medication Tubes
        • Other Types
        • Plastic Bottles
        • Pouches & Strip Packs
        • Pouches & Strips
        • Prefilled Inhalers
        • Prefilled Syringes
        • Temperature-Controlled Packaging
        • Vials

        By Packaging Type

        • Primary
        • Secondary

        By Drug Delivery Mode

        • Injectable
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        Target Audience

        • Pharmaceutical Manufacturers : Australian and international pharma companies need market data to optimize packaging strategies, ensure regulatory compliance, and capitalize on the country's growing domestic and export opportunities.
        • Packaging Solution Providers : Packaging manufacturers and suppliers require detailed market insights to identify growth segments, understand customer needs, and develop targeted solutions for Australia's high-growth pharmaceutical sector.
        • Investment & Private Equity Firms : Investors evaluating opportunities in Australian pharmaceutical infrastructure need comprehensive market analysis to assess growth potential, competitive dynamics, and ROI prospects in the packaging segment.
        • Healthcare & Regulatory Consultants : Consultants advising pharmaceutical clients on market entry, expansion, or compliance strategies require Australia-specific data to provide informed recommendations aligned with local regulatory and market conditions.
        • Supply Chain & Procurement Managers : Procurement professionals in pharmaceutical companies need market forecasts and supplier landscape data to make informed sourcing decisions and negotiate contracts with Australian packaging vendors.

        Key Companies in the Australia Pharmaceutical Packaging Market

        CompanyHQOwnershipStrongest segments
        TASNEESaudi ArabiaPublic CompanyPetrochemicals (PE, PP compounds, acrylics, solvents),Metallurgy (titanium sponge, slag, pig iron, lead),Downstream plastics (BOPP films, pipes, pallets, agrifilm, sheets, liners),
        LG CHEM LTD.South KoreaPublic CompanyEthylene- and propylene-based synthetic resins,Styrene-based resins and polycarbonate,Advanced materials and battery-related chemistries,
        BOBST GROUP SASwitzerlandPrivate CompanyFolding carton converting (flatbed die-cutters, folder-gluers, related tooling and services),Corrugated board equipment (flexo printing, rotary die-cutters, folder-gluers, converting lines),Flexible packaging and label equipment (vacuum metallizers, coating/laminating, CI/inline flexo, gravure, digital),
        GERRESHEIMER AGGermanyPublic CompanyPrimary Packaging Glass (vials, cartridges, ampoules, flacons),Plastics & Devices (syringes, bottles, closures, medical disposables),Advanced Technologies & Drug Delivery Devices,
        SCHOTT AGGermanyPublic CompanyPrefillable glass syringes (syriQ portfolio),Pharmaceutical glass vials (adaptiQ, EVERIC family),Cartridges (cartriQ and related),
        APTARGROUP, INC.United StatesPublic CompanyPharma (drug delivery, elastomeric components, active material science, digital health),Beauty (fragrance, facial skincare, color cosmetics dispensing),Closures (food, beverage, personal and home care closures and aerosol valves),
        BDUnited StatesPublic Company
        WESTROCK COMPANYUnited StatesPrivate CompanyConsumer packaging solutions,Corrugated packaging solutions,Merchandising display solutions,

        TASNEE

        TASNEE is a Saudi Arabian public company founded in 1984 with 7,000 employees, operating in the petrochemicals and industrial materials industry.

        LG CHEM LTD.

        LG Chem Ltd. is a South Korean public company founded in 1947 with 14,019 employees, specializing in chemicals, advanced materials, and energy solutions.

        BOBST GROUP SA

        Bobst Group SA is a Swiss private company founded in 1890 with 6,314 employees, manufacturing machinery and equipment for the packaging and printing industries.

        GERRESHEIMER AG

        Gerresheimer AG is a German public company founded in 1864 with 13,528 employees, manufacturing specialty glass and plastic packaging for pharmaceuticals and cosmetics.

        SCHOTT AG

        Schott AG is a German public company founded in 1884 with 4,839 employees, producing specialty glass and glass-ceramics for various industrial applications.

        APTARGROUP, INC.

        AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees, manufacturing dispensing systems and packaging solutions for beauty, personal care, and pharmaceutical markets.

        BD

        BD (Becton, Dickinson and Company) is a United States public company founded in 1897 with 72,000 employees, specializing in medical devices, diagnostics, and laboratory equipment.

        WESTROCK COMPANY

        WestRock Company is a United States private company founded in 2018 with 56,100 employees, operating as a major manufacturer of paper and packaging products.

        Reasons to Buy this Report

        • Market-Specific Growth Intelligence : Gain detailed insights into Australia's 17.5% CAGR trajectory and understand the unique drivers propelling the market faster than global averages, enabling strategic investment decisions tailored to the Australian pharmaceutical landscape.
        • Competitive Positioning Data : Access comprehensive analysis of Australia's strengthening Asia-Pacific position, identify emerging competitors, and benchmark your market share against regional players to optimize your competitive strategy.
        • Regulatory Compliance Framework : Understand TGA-specific packaging requirements, compliance standards, and regulatory trends shaping the Australian market, ensuring your products and strategies align with local regulatory expectations.
        • Investment & Expansion Opportunities : Identify high-growth segments within Australia's $9.2B forecasted 2030 market, pinpoint geographic hotspots, and discover partnership opportunities with domestic manufacturers and distributors.
        • Demand Forecasting & Planning : Leverage precise market projections through 2030 to optimize supply chain planning, inventory management, and production capacity decisions specific to the Australian pharmaceutical packaging sector.

        Frequently asked questions

        What is the current size of Australia's pharmaceutical packaging market?

        Australia's pharmaceutical packaging market is valued at $4,116.1 million in 2025 and is projected to grow to $9,231.4 million by 2030.

        What is the growth rate for Australia's pharmaceutical packaging market?

        Australia's pharmaceutical packaging market is growing at a compound annual growth rate (CAGR) of 17.5% from 2025 to 2030.

        What factors are driving growth in Australia's pharmaceutical packaging market?

        Australia's market growth is driven by regulatory compliance requirements, biopharmaceutical manufacturing expansion, advanced drug delivery demand, and sustainability initiatives.

        How does Australia's pharmaceutical packaging market compare to global trends?

        Australia's 17.5% CAGR significantly outpaces the global pharmaceutical packaging market CAGR of 15.8%, reflecting Australia's strong regional position.

        What packaging innovations are emerging in Australia's pharmaceutical sector?

        Australia's market is seeing increased adoption of sustainable materials, smart packaging technologies, and advanced compliance solutions aligned with TGA standards.

        RESEARCH METHODOLOGY

        The study involved four major activities to estimate the current size of the global pharmaceutical packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the pharmaceutical packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

        Secondary Research

        The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the pharmaceutical packaging market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the pharmaceutical packaging market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Pharmaceutical Packaging Market Size, and Share

        Notes: Other designations include sales, marketing, and product managers.
        Tier 1: Revenues greater than USD 1 Billion; Tier 2: Revenues between USD 500 million and USD 1
        Billion; and Tier 3: Revenues less than USD 500 million

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        The top-down and bottom-up approaches were used to estimate and validate the size of the global pharmaceutical packaging market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

        Pharmaceutical Packaging Market : Top-Down and Bottom-Up Approach

        Pharmaceutical Packaging Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

        Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

        Stakeholders

        • Pharmaceutical packaging manufacturers
        • Raw material suppliers
        • Converters & processors
        • Distributors and traders
        • Industry associations and regulatory bodies
        • End users

        Report Objectives

        • To define, describe, and forecast the size of the pharmaceutical packaging market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
        • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
        • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
        • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
        • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
        • To strategically profile key players and comprehensively analyze their market shares and core competencies
        • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the pharmaceutical packaging market
        • To provide the impact of AI/Gen AI on the market

        Available Customizations

        With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

        The following customization options are available for the pharmaceutical packaging market report:

        Product Analysis

        • A product matrix that gives a detailed comparison of the product portfolio of each company

        Geographic Analysis as per Feasibility

        • A further breakdown of the pharmaceutical packaging market for additional countries

        Company Information

        • Detailed analysis and profiling of additional market players (up to five)

        Get the Full Pharmaceutical Packaging Market Report

        Full forecast, segment splits, and company analysis for all Pharmaceutical Packaging Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status